Get the SPI Wire

Turn Therapeutics Inc.

NASDAQ:TTRX
Annual Meeting

of Shareholders

MEETING DATE

11/30/2026
DEF 14A FILED
10/19/2026
PUBLISHED
10/19/2026 8:05 pm
TIME TO PUBLISH
10/21/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:TTRX · CUSIP 90021W105 · CLASS common stock, par value $0.0001 per share · CIK 0002023016

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1.01
Bradley Burnam
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated Bradley Burnam to serve until the 2029 annual meeting of stockholders.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.02
Dr. Neil Ghodadra
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated Dr. Neil Ghodadra to serve until the 2029 annual meeting of stockholders.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To ratify the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Audit committee selected Withum, and filing states no disagreements or reportable events with the former auditor.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

65528ccbfdd7e7a8143f0bb1f3352f3573ad1738fc103f31d56d7a30950cb387

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates